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ABSTRACT
Objectives: To identify the role of fitness, fitness
change, body mass index and other factors in
predicting long-term (>5 years) survival in patients
with coronary heart disease.
Design: Cohort study of patients with coronary heart
disease recruited from 1 January 1993 to 31 December
2002, followed up to March 2011 (1 day to 18 years
3 months, mean 10.7 years).
Setting: A community-based National Health Service
(NHS) cardiac rehabilitation programme serving the
Basingstoke and Alton area in Hampshire, UK.
Participants: An unselected cohort of NHS patients,
2167 men and 547 women aged 28–88 years, who
attended the rehabilitation programme following acute
myocardial infarction, an episode of angina or
revascularisation, and had a baseline fitness test.
Main outcome measures: Cardiovascular mortality
and all-cause mortality.
Results: A high level of fitness (VO2≥22 mL/kg/min
for men, VO2≥19 mL/kg/min for women) at completion
of the programme was associated with decreased all-
cause death, as was a prescription for statins or
aspirin, and female gender. Increase in all-cause
mortality was associated with higher age and ACE
inhibitors prescription. Higher risk of cardiovascular
mortality was associated with increasing age,
prescriptions for ACE inhibitor, and diagnosis of
myocardial infarction or angina as compared with the
other diagnoses.
Conclusions: Prior fitness and fitness improvement
are strong predictors of long-term survival in patients
who have experienced a cardiac event or procedure.
Some secondary prevention medications make a
significant contribution to reducing all-cause mortality
and cardiovascular mortality in these patients. This
study supports public health messages promoting
fitness for life.
INTRODUCTION
We report the long-term mortality of an
unselected cohort of patients who have
experienced a coronary event or procedure.
While many studies have reported on the
effects of treatment and other factors on
short-term case fatality,1–4 there is little
evidence published on the role of ﬁtness,
ﬁtness change, depression and anxiety, and
other factors which may be associated with
the long-term survival of individuals who
have experienced a coronary event (eg, myo-
cardial infarction (MI)) or procedure (eg,
coronary artery bypass graft (CABG), percu-
taneous coronary intervention (PCI)).5–10 In
addition, the relative importance of two
modiﬁable factors, ﬁtness and body mass
index (BMI), has yet to be fully explored.
Coronary heart disease remains the leading
cause of mortality in the UK, with coronary
heart disease accounting for 18% of all deaths
in men and 13% in women.11 Nevertheless,
the UK has been experiencing dramatic falls
in death rates from coronary heart disease in
recent years12 due to the fall in smoking
prevalence13 and improvements in the treat-
ment, particularly secondary prevention.14
In this analysis, we investigated the factors
that inﬂuenced long-term survival after a cor-
onary event. We were particularly interested
in the effects of ﬁtness, body weight and
depression.
METHODS
Setting and participants
We used data collected by one of us (ST) on
patients recruited between 1 January 1993
Strengths and limitations of this study
▪ Unselected cohort of patients registered in a
National Health Service cardiac rehabilitation
centre.
▪ All data collected by one individual.
▪ Long-term follow-up of participants; mean
10 years 8 months.
▪ Effect of missing data examined using multiple
imputations.
▪ Dietary factors, postrehabilitation exercise and
medications unknown; height and ethnicity not
routinely recorded throughout.
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and 31 December 2002 through the Basingstoke
and Alton (Hampshire, UK) cardiac rehabilitation
programme15–17 with follow-up to 30 March 2011. The
cohort was unselected, included all National Health
Service (NHS) referrals, and participants have now been
followed for 1 day to 18 years and 3 months providing
11 871 person-years of follow-up. Recruitment to the
cohort was undertaken typically 2 –6 weeks after their
index coronary event.18 19 NHS patients in the area
served by the rehabilitation centre were routinely
referred to this programme following an acute MI,
episode of unstable angina or revascularisation. The
only other inclusion criterion for the study was that the
patients had to be registered with the cardiac rehabilita-
tion programme. This resulted in an unselected cohort
of 2714 patients.
The phase III programme —offered at Basingstoke
and Alton cardiac rehabilitation centre—assessed
patients for physical and psychological health at the
beginning and at the end of the programme. They
began a supervised aerobic exercise class once or twice a
week, with home aerobic exercises in between. The
supervised sessions comprised circuit training for
40 min, with those patients needing to rest between dif-
ferent aerobic exercises switching to strength and endur-
ance exercises for ‘active recovery’. Patients graduated
from the exercise programme when they could complete
the circuit without needing active recovery. Besides the
exercise programme,20 a health education and stress
management component was offered to which patients’
spouses or partners were also invited. This component
covered relaxation techniques and a health education
programme (understanding coronary heart disease,
cholesterol, healthy eating, blood pressure, the beneﬁts
of regular physical activity, smoking advice, cardiac medi-
cations), and stress management.
Data
Dates and causes of death were provided by the Ofﬁce
for National Statistics. All patients who attended the pro-
gramme and had baseline ﬁtness measured were
included in the primary analysis. Data collected included
whether the programme was completed, diagnosis,
comorbidity, family history, occupation, date of birth,
age, gender, smoking history, resting heart rate, choles-
terol level, triglycerides level, postcode and from 1998,
height. At both recruitment and on completion records
were made of each patient’s weight, blood pressure,
ﬁtness, anxiety and depression21 22 (as measured by
Hospital Anxiety and Depression Scale17 23), current
smoking habit and medications (ACE inhibitor, aspirin,
β-blocker, statins).
We calculated changes in weight, ﬁtness, anxiety and
depression from the entry and exit values for each indi-
vidual. Since height was not routinely recorded through-
out, BMI was available for only 889 patients; so, for the
primary analysis, we categorised baseline weight into
under 78 kg, 78–93 kg and over 93 kg for men, and
under 68 kg, 68–80 kg and over 80 kg for women; these
categories were labelled I, II and III, respectively, for
brevity. These approximate to the normal, overweight
and obese categories for men and women of average
height (176 cm and 164 cm, respectively; British
National Formulary) and the average age of this cohort.
The index of multiple deprivation was ascertained from
postcode, occupation was coded under nine headings
(see table 1), and age was categorised into under 50,
50–59, 60–69 and 70 years and over. The Modiﬁed
D’Hoore comorbidity index is designed to assess non-
coronary comorbidity speciﬁcally in the outpatient
cardiac rehabilitation environment, rather than in the
acute setting,24 and was calculated for each patient
based on the recorded comorbidities.
Up to August 1995, ﬁtness was assessed on a bicycle
ergometer with ECG monitoring and measurement of
estimated peak workload. After that date, exercise tests
were performed on a treadmill—without using a hand-
rail, using either the Bruce protocol25 or, the modiﬁed
Bruce protocol, for frail or elderly patients.26 Peak exer-
cise tolerance was expressed as the predicted oxygen
uptake (VO2peak) in mL/kg/min, from the known
oxygen cost of bicycling at different workloads.27 The
same end points were used as for bicycle tests and
VO2peak predicted on the assumption that each 1 min
of the Bruce protocol uses 1 MET (metabolic equivalent
—or 3.5 mL O2/kg/min), and that the ﬁrst three stages
of the modiﬁed Bruce protocol each use 1 MET.
VO2peak<15 mL/kg/min was categorised as low ﬁtness,
VO2peak>22 mL/kg/min as high ﬁtness, and the
in-between readings as medium ﬁtness for males (cat-
egories established for cardiac rehabilitation by
Kavanagh et al 28 29); for females VO2peak<13 mL/kg/
min was categorised as low ﬁtness, VO2peak>19 mL/kg/
min as high ﬁtness,and the in-between values were cate-
gorisedas medium.28 30
Depression and anxiety were categorised into none,
borderline and depressed or anxious using a Hospital
Anxiety and Depression Scale score below 8 to suggest
no depression or anxiety, 8–10 to suggest borderline,
and a score over 10 to suggest clinical depression or clin-
ical anxiety.23
We are conﬁdent that all deaths in UK have been cap-
tured and the loss to follow-up will have been minimal,
perhaps due to deaths which occurred abroad and were
not reported to the study.
In the main analysis, baseline categories of ﬁtness,
depression and anxiety were used as predictors. In order
to test whether an improvement in ﬁtness, depression
and anxiety categories inﬂuenced survival, and whether
these depend on baseline categories, we deﬁned
variables ﬁtness, anxiety and depression where a scale of
1–7 captured each starting category and the improve-
ment or deterioration (see online supplementary table
S6, which details the categories). Very few patients
started in the highest ﬁtness category and then deterio-
rated over the course of the programme (5 men); so we
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Table 1 Baseline values for patients at recruitment to cardiac rehabilitation programme
Male Female Total
Number (n) 1320 (86.3%) 209 (13.7%) 1529 (100%)
Mean years of follow-up (SD) 11.3 (3.8) 11.1 (3.6) 11.3 (3.7)
Mean age in years (SD) 61.0 (9.4) 62.9 (9.0) 61.3 (9.4)
n Per cent n Per cent n Per cent
Age (years)
<50 158 11.9 19 9.1 177 11.5
50–59 405 30.7 50 23.9 455 29.8
60–69 500 37.9 85 40.7 585 38.3
>70 257 19.5 55 26.3 312 20.4
Diagnostic category
MI 673 51.0 108 51.7 781 51.1
CABG 382 28.9 51 24.4 433 28.4
PCI 124 9.4 22 10.5 146 9.5
MI+PCI 56 4.3 7 3.3 63 4.1
Angina 61 4.6 19 9.1 80 5.2
Other cardiac diagnoses 24 1.8 2 1.0 26 3.8
Smoking history
Never smoked 347 26.3 93 44.4 440 28.8
Not for >10 years 430 32.6 30 14.4 460 30.1
Not for 1–10 years 56 4.2 9 4.3 65 4.3
Recent quitter 407 30.8 64 30.6 471 30.8
Current smoker 80 6.1 13 6.3 93 6.0
D’Hoore comorbidity score
None 968 73.3 141 67.5 1109 72.5
1 (least) 150 11.4 22 10.5 172 11.2
2 168 12.7 42 20.1 210 13.7
3 21 1.6 3 1.4 24 1.6
4 (most) 13 1.0 1 0.5 14 1.0
Diagnosis of diabetes 158 12.0 29 13.9 187 12.2
Family history of CHD 613 46.4 115 55.0 728 47.6
Weight at baseline
I: <78 kg men; <68 kg women 519 39.3 95 45.5 614 40.2
II: 78–93 kg men; 68–80 kg women 565 42.8 69 33.0 634 41.5
III: >93 kg men; >80 kg women 236 17.9 45 21.5 281 18.3
Medications
ACE inhibitor
No 665 50.4 88 42.1 753 49.2
Yes 655 49.6 121 57.9 776 50.7
Aspirin
No 45 3.4 12 5.7 57 3.7
Yes 1275 96.6 197 94.3 1472 96.3
Statin
No 455 34.5 57 27.3 512 33.5
Yes 865 65.5 152 72.7 1017 66.5
β-blockers
No 727 55.1 108 51.7 835 54.6
Yes 593 44.9 101 48.3 694 45.4
Occupation
Managers and senior officials 236 17.9 16 7.6 252 16.5
Professional occupations 143 10.8 11 5.3 154 10.1
Associate professional 145 11.0 25 12.0 170 11.1
Administrative and secretarial 125 9.5 67 32.1 192 12.6
Skilled trade 362 27.4 13 6.2 375 24.5
Personal service 23 1.7 34 11.5 47 3.1
Sales and customer 26 2.0 16 7.6 42 2.7
Process, plant and machines 155 11.7 12 5.7 167 10.9
Elementary occupations 105 8.0 25 12.0 130 8.5
Continued
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combined this category with the ‘no change’ category.
There were no patients who deteriorated after having
started in the mid-ﬁtness category; therefore, we omitted
this category and were ﬁnally left with ﬁve categories.
We deﬁned survival time as the period between the date
the participant joined the programme and the date of
death. In the survival analyses, we considered all-cause
mortality and cardiovascular mortality, with non-
cardiovascular deaths treated as censored in the latter
analysis.
Statistical analysis
We used Cox proportional hazards models31 starting
with the subset of variables that were found to be signiﬁ-
cant predictors (at 5% level) of all-cause mortality in the
univariate analyses. We employed a backward stepwise
selection algorithm to ﬁnd the model with minimum
Akaike Information Criterion (AIC),32 retaining age and
gender as the minimum model. All analyses were carried
out in R statistical software.33 The primary model
(model A) was based on 1529 cases with complete data,
including a baseline ﬁtness test. Two secondary models
were also produced. One used the 1029 cases with com-
plete data—including a baseline and end ﬁtness test—to
study the effects of ﬁtness change (model B) on long-
term survival. The other used the 889 cases with a base-
line ﬁtness test and a baseline BMI measurement to
evaluate the relative effect of BMI and ﬁtness (model C)
on long-term survival.
Since there was a large amount of missing data, we
assessed the credibility of the complete-case model.
Analysis of a complete-case data set alone cannot be
expected to give reliable estimates of model coefﬁcients
without making assumptions about the missing data.34
We compared HRs from the complete-case analysis with
those from an analysis of all data after replacement of
missing values with imputed data. Multiple imputation
was performed in the R package MICE (Multivariate
Imputation using Chained Equations)33 providing 20
completed data sets with values imputed where these
were missing. The optimised model was then built with
each of these 20 data sets, and pooled estimates of
model coefﬁcients and variances calculated using the
rules devised by Little and Rubin34 for comparison.
There were no known reasons to believe that the data
were missing other than at random, except in the case
of the end ﬁtness data. Reasons for end ﬁtness to be
missing included referral for cardiac surgery and poor
health; a Student t test conﬁrmed that time to death for
these individuals differed from those with end ﬁtness
observations.
RESULTS
Patient characteristics
Of the 2964 patients with coronary heart disease
recorded on the database, 160 did not attend any part
of the rehabilitation programme, 1 of them had a MI
suspected to be secondary to anorexia nervosa, another
was 18-year-old probably a miscode, and 88 did not have
a ﬁtness assessment at entry to the programme; this left
2714 patients. A total of 2054 patients completed the
programme17; the main reasons for not completing the
programme were patient preference, referral for cardiac
surgery, poor health or death. Those without complete
end ﬁtness data included the ones who were taken to a
different heart rate at the ﬁnal ﬁtness test, most of
whom were on a β-blocker for which the dose had been
changed or who were tested at a different time of day,
and those who were tested using a different test proto-
col.17 The mean follow-up for those with complete data
was 11 years 4 months.
There were 1529 cases (56.3%) which were complete
in all the 36 variables that were signiﬁcant in the univari-
ate analysis and became the starting point for the
primary analysis (model A), see ﬁgure 1. Patient
characteristics for these are given in table 1. There were
1029 cases (38%) which were complete in the variables
used in the primary analysis and also had observations
Table 1 Continued
Male Female Total
Fitness
High baseline 588 44.6 53 25.4 641 41.9
Mid baseline 511 38.7 77 36.8 588 38.5
Low baseline 221 16.7 79 37.8 300 19.6
Depression
Not depressed 1162 88.0 160 76.6 1322 86.5
Borderline 113 8.6 36 17.2 149 9.7
Depressed 45 3.4 13 6.2 58 3.8
Anxiety
Not anxious 930 70.5 122 58.4 1052 68.8
Borderline 251 19.0 42 20.1 293 19.2
Anxious 139 10.5 45 21.5 184 12.0
Median VO2 mL/kg/min (10th, 90th centile) 21.0 (13.1, 29.7) 15.5 (8.4, 24.5) 20.1 (11.0, 29.2)
CABG, coronary artery bypass graft; CHD, coronary heart disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.
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for ﬁtness, depression and anxiety at the end of the pro-
gramme, allowing us to assess the impact of changes in
these variables on survival (model B). Patient character-
istics for these are given in online supplementary table
S5. There were 889 cases (32.8%) for which it was pos-
sible to calculate BMI and were complete in the other
variables (model C). Patient characteristics for these are
given in online supplementary table S7.
Women (13.7%) had a higher mean age. The most
common reason for referral to the programme was
acute MI (51.1%). Nearly half the women had never
smoked compared with just under one-third of the
men, and close to one-third of both genders had
recently given up smoking. Around half of all patients
had a family history of coronary heart disease and over
70% were free from non-coronary comorbidity,
although a higher proportion of the women had
diabetes. The men had a higher mean ﬁtness than the
women, and the percentage of men in the high-ﬁtness
category at recruitment was twice that of the women. At
completion, 67% of the men and 41% of the women
were in the high-ﬁtness category, with one-ﬁfth of the
patients having improved from the mid-ﬁtness category.
Median ﬁtness was improved by a similar amount in
both genders, and high ﬁtness was the largest group at
completion.
There was little evidence of clinical depression in this
cohort, and most of those whose scores suggested a bor-
derline category improved by programme completion
(83%), as did almost all of the few whose scores at
recruitment suggested clinical depression (83%). There
was more anxiety, although the rates were not high.
Again, the majority who began in the borderline cat-
egory improved, as did a signiﬁcant proportion of those
starting in the clinical anxiety category, but the propor-
tion of women who remained in the clinical anxiety
class was three times that of the men. The maximum
recorded comorbidity score was 7 (very high), but only
2.6% of participants had a comorbidity score of 3 or
more (see online supplementary table S2 for scoring
details).24
Survival
During the course of the study and follow-up, 385 parti-
cipants (25.2%) died and of these deaths, 192 (49.9%)
were from cardiovascular causes.
For model A, the primary proportional hazards model,
the signiﬁcant predictors of all-cause mortality are pre-
sented in table 2. In this model, age was the most import-
ant predictor of all-cause mortality, with risk of death
increasing with age. The next most important predictor
was ﬁtness category at recruitment, with the ﬁttest
patients having the lowest risk. Risk increased with
comorbidity, and aspirin and statins prescriptions
reduced risk. MI was the diagnosis carrying the greatest
risk, including MI with PCI, angina and other cardiac
diagnoses. CABG and PCI alone were much lower risk
diagnoses. Those with a lower resting heart rate were at a
lower risk of mortality. Higher systolic blood pressure
was also a risk indicator. ACE inhibitor prescription was
Figure 1 The number of
patients* with missing data in
individual variables of interest
varied, with fitness after the
programme missing in 48.5% of
cases, and the remaining
variables missing data ranging
between 0% and 29.4%. Details
of variables and numbers, and
percentage of missing
observations are provided in
online supplementary table S1
(BMI, body mass index).
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associated with higher risk; the most likely reason for this
is that at the time these drugs were being prescribed the
ACE inhibitors were only given to individuals at high
risk. That is, the users of ACE inhibitors will have been at
higher risk than non-users before starting to use the
medication. After adjusting for other factors, gender was
not a statistically signiﬁcant predictor of mortality. The
signiﬁcant terms from the cardiovascular mortality
model are detailed in table 3. Fitness category at baseline
was the strongest predictor of cardiovascular mortality,
with higher ﬁtness associated with lower risk. A prescrip-
tion for statins cut the risk of cardiovascular mortality by
more than half in this cohort. Age was the next most sig-
niﬁcant predictor of mortality, with risk increasing with
age as expected. As with all-cause mortality, a diagnosis
of MI carried the highest associated risk of mortality,
with MI+PCI, angina and other cardiac diagnoses having
an equally high mortality risk. A prescription for ACE
inhibitor was associated with higher risk.
The all-cause mortality for model B, the cohort having
complete data including end depression anxiety and
ﬁtness, is detailed in online supplementary table S3. In
model B, age was the strongest predictor of risk for all-
cause mortality, followed by the combination of ﬁtness
category at recruitment, and whether the patient
improved or maintained that ﬁtness, with highest risk
attributed to those who began in the low-ﬁtness category.
Mean VO2peak change was 3.81 VO2 mL/kg/min
Table 2 All-cause survival model A (using only baseline
fitness, anxiety and depression categories), ordered by
importance of variables to the model (1529 cases, 385
deaths)
Complete cases Imputed
data95% CI
Model term HR Lower Upper HR
Age category(years)
<50 1.00 – – 1.00
50–59 2.13 1.17 3.88 2.04
60–69 3.85 2.15 6.89 3.09
>70 7.96 4.38 14.44 6.12
Fitness at baseline
High baseline 1.00 – – 1.00
Mid baseline 1.54 1.16 2.05 1.75
Low baseline 2.47 1.78 3.42 2.67
D’Hoore comorbidity
None 1.00 – – 1.00
1 (least) 1.23 0.91 1.66 1.74
2 1.42 1.08 1.86 1.40
3 1.35 0.68 2.66 1.96
4 (most) 4.50 2.13 9.50 2.09
Statins
Yes 0.72 0.57 0.89 0.74
No 1.00 – – 1.00
Aspirin
Yes 0.52 0.35 0.78 0.63
No 1.00 – –
Systolic blood
pressure before:
each 1 mm Hg
reduction
0.995 0.993 0.999 0.998
ACE inhibitor
Yes 1.26 1.01 1.57 1.18
No 1.00 – – 1.00
Resting heart rate 1.007 1.000 1.014 1.007
Diagnostic category
MI 1.00 – – 1.00
CABG 0.69 0.54 0.89 0.69
PCI 0.53 0.32 0.88 0.67
MI+PCI 0.84 0.44 1.65 0.79
Angina 0.87 0.54 1.39 0.84
Other cardiac
diagnoses
0.99 0.44 2.25 0.93
Gender
Male 1.0 – – 1.00
Female 0.79 0.59 1.06 0.69
CABG, coronary artery bypass graft; MI, myocardial infarction;
PCI, percutaneous coronary intervention.
Table 3 Optimised cardiovascular survival model A
(using only baseline fitness, anxiety and depression
categories), ordered by importance of variables to the
model (1529 cases, 192 cardiovascular deaths)
Model term
Complete cases Imputed
data95% CI
HR Lower Upper HR
Fitness
High baseline 1.00 – – 1.00
Mid baseline 1.83 1.20 2.79 2.34
Low baseline 4.06 2.58 6.39 4.26
Statin
Yes 0.45 0.33 0.61 0.51
No 1.00 – –
Age (years)
<50 1.00 – – 1.00
50–59 1.58 0.76 3.31 1.53
60–69 2.63 1.30 5.35 2.39
>70 4.00 1.93 8.28 3.77
Diagnostic category
MI 1.00 – – 1.00
CABG 0.60 0.42 0.85 0.62
PCI 0.26 0.09 0.70 0.49
MI+PCI 1.05 0.42 2.62 0.74
Angina 0.85 0.46 1.53 0.72
Other cardiac
diagnoses
0.79 0.25 2.49 0.99
Aspirin
Yes 0.47 0.28 0.78 0.57
No 1.00 – – 1.00
Gender
Male 1.00 – – 1.00
Female 0.73 0.48 1.10 0.62
ACE inhibitor
Yes 1.42 1.04 1.94 1.36
No 1.00 – – 1.00
CABG, coronary artery bypass graft; MI, myocardial infarction;
PCI, percutaneous coronary intervention.
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(SD 3.38). There was no statistically signiﬁcant differ-
ence (assessed at the 5% level) between those who
began in the mid-ﬁtness category and improved to high
ﬁtness and those who began in the high-ﬁtness category
and maintained high ﬁtness. However, those who did
not improve sufﬁciently to move up from the mid-ﬁtness
category had signiﬁcantly higher risk; improvement to a
mid-ﬁtness from low-ﬁtness category did not signiﬁcantly
reduce risk, although a signiﬁcant difference in risk is
evident between low and medium ﬁtness for the patients
whose category did not change. Having a prescription
for statins or having a prescription for aspirin was each
associated with a lower risk of mortality. A prescription
for ACE inhibitors was associated with a higher risk of
mortality.
The cardiovascular mortality for model B is detailed
in online supplementary table S4. Fitness was the most
powerful predictor of cardiovascular mortality, low base-
line and failure to improve being powerful predictors of
cardiovascular mortality. A prescription for statins was
important, with those having a prescription having
one-third the risk of those without. After ﬁtness, age was
the most important factor, with those over 70 years at
higher risk of cardiovascular death. Aspirin was asso-
ciated with lower risk of mortality.
The all-cause and cardiovascular mortality for model
C, with BMI as a prognostic factor, is detailed in online
supplementary tables S8 and S9. Model C was very
similar to the primary model. Notably, while BMI was a
predictor of mortality in the univariate analysis, in the
presence of a ﬁtness assessment it ceased to be statistic-
ally signiﬁcant. This suggests that an assessment of
ﬁtness may be a better prognosis of survival than a
measure of obesity in people with coronary disease.
Imputed data
The HRs derived from the pooled imputed data (shown
in tables 2 and 3) are reassuringly very similar to those
from the complete-cases model, both in size and direc-
tion, indicating that missing data has not signiﬁcantly
modiﬁed the inferences we report.
DISCUSSION
We set out to discover which factors predict mortality in
an unselected cohort of patients attending cardiac
rehabilitation. We found that having a good level of
ﬁtness before a coronary event or procedure confers a
survival advantage. Also, individuals who increase ﬁtness
during cardiac rehabilitation could increase life expect-
ancy, even if they were already moderately ﬁt.
Four major strengths of this study are that there was a
long follow-up period, the participants were unselected,
ﬁtness was assessed at entry into rehabilitation, and all
the data were collected in routine clinical practice by
one physiotherapist (ST) using a consistent ﬁtness deliv-
ery programme. The data reported here are derived
from a single NHS centre, with a consistent delivery of
the programme spanning 18 years (average follow-up
11.5 years). Since all patients registered in the pro-
gramme with a baseline ﬁtness test were included, the
participants represent a realistic sample of the popula-
tion of people who are likely to access cardiac
rehabilitation.
The majority of trials of cardiac rehabilitation have
followed participants for 2 years or less,17 and of the
studies that have reported on long-term survival, very
few consider ﬁtness as a possible explanatory vari-
able.13 14 35 However, a recent Canadian study of a
similar duration to ours, but which followed a selected
cohort of patients,30 also found that baseline ﬁtness and
ﬁtness improvement were associated with reduced all-
cause mortality. The authors selected a group of patients
who had undergone cardiac catherisation procedures,
had completed a 12-week exercise-based cardiac rehabili-
tation course, had returned 12 weeks later for a repeated
assessment, and had survived for at least 6 months from
the date of catherisation. There were no missing data.
The study participants were of a similar age range and
gender balance as those in our study, but their baseline
ﬁtness was higher.
Our ﬁndings were based on routinely collected clin-
ical data in an unselected group of patients, with inevit-
ably some missing data. However, we have been able to
demonstrate the robustness of our models using estab-
lished statistical methods. Physical ﬁtness was assessed
indirectly using predicted, not measured, oxygen
uptake. Over the course of the study, two different
methods of estimating ﬁtness were used. However, we
ensured that only patients whose ﬁtness was assessed by
the same method at the beginning and the end of
cardiac rehabilitation programme were included in the
variable measuring change in ﬁtness. Furthermore,
method of ﬁtness assessment was not statistically signiﬁ-
cant in the survival models. The methods of ﬁtness
assessment are typical of the pragmatic methods used in
such NHS settings.36 Patients who did not have a base-
line measure of ﬁtness were excluded, diminishing the
generalisability of the results. Some of these individuals
will have been the frailest patients. Lower VO2peak esti-
mated from a treadmill test can indicate more severe
cardiovascular disease as well as lower ﬁtness, and it may
be that those patients with low ﬁtness also have more
severe cardiovascular disease.
Attaining a ﬁtness level of VO2≥22 mL/kg/min for
men and VO2≥19 mL/kg/min for women in the
early months following a cardiac event or procedure is
associated with improved long-term survival. For
comparison, a man aged 60+ with a VO2peak of
26.1–32.2 mL/kg/min is considered reasonably ﬁt and
32.3–36.4 mL/kg/min, as very ﬁt;37 so these ﬁtness
categories are not very demanding. High ﬁtness at
recruitment to the rehabilitation programme was likely
to reﬂect high ﬁtness before a coronary event or proced-
ure, but there was no statistically signiﬁcant difference
between patients who improved from moderate ﬁtness at
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recruitment to high ﬁtness at programme completion
and those who maintained high ﬁtness from recruit-
ment. Since we have followed these patients for a mean
of 10.7 years, and have no information on what their
levels of exercise or ﬁtness were during those years, it is
even more striking that a brief snapshot of their past
ﬁtness should show such a strong effect on long-term
survival. If long-term data on ﬁtness were available, it
may be that the effect would prove to be even stronger.
Measured VO2peak was found to be a predictor of long-
term mortality of men and women in Canada in the
earlier decades, without consideration of change in
ﬁtness; even moderate ﬁtness conferred a 50% reduc-
tion in cardiac mortality.28 29
Having adjusted for ﬁtness, BMI does not appear to
affect all-cause or cardiovascular mortality in patients
with cardiovascular disease, which is consistent with
other studies.10 30 38–40 These ﬁndings are in line with
those of a recent large European cohort study which
examined reported physical activity and measures of
obesity as predictors of all-cause mortality, and con-
cluded that physical inactivity ‘is responsible for more
than twice as many deaths as general obesity’.40
Using medications for secondary prevention, particu-
larly aspirin and statins, in the early weeks after a cardiac
event or procedure appears to reduce long-term
mortality from cardiovascular causes and all-causes. This
conﬁrms previous ﬁndings.14 Given that we have no
information on adherence or changes to medication
after completion of the programme, the strong effect of
secondary preventative medication is striking. Analysis of
data sets with information on the long-term use of medi-
cations might show an even stronger effect. Preoperative
risk factors which are good predictors of short-term out-
comes have been found to contribute little information
to the prediction of long-term survival in patients with
CABG.7 Traditional predictors of early survival in
patients with CABG over the age of 65 years do not
affect long-term survival,10 but late mortality is increas-
ingly associated with chronic diseases and health beha-
viours. Long-term prognosis after hospital admission for
MI is improving.41 In the majority of previous studies,
differences between cardiovascular mortality and all-
cause mortality were not considered, and nor were sec-
ondary prevention medications, ﬁtness or anxiety and
depression considered as predictors of survival.
Health may be expected to be generally better in an
afﬂuent area, such as the one selected for this study,
than in a deprived geographical area; thus these results
may not be fully generalisable to other settings. Patients
who never attended or attended but did not have a base-
line assessment of ﬁtness are excluded from this analysis,
but they may form part of the population of patients typ-
ically experiencing a cardiac event or procedure,
Figure 2 Kaplan-Meier survival
curves for all-cause and
cardiovascular mortality. The plot
is for the entire observation
period and the dashed lines are
95% CIs.
Figure 3 Kaplan-Meier survival
curves for all-cause and
cardiovascular mortality by
baseline fitness group. The plot is
for the entire observation period
with 95% CIs.
8 Barons MJ, et al. BMJ Open 2015;5:e007772. doi:10.1136/bmjopen-2015-007772
Open Access
potentially diminishing the generalisability of the results.
Some of these individuals will have been the frailest
patients, and excluding them also explains the initial
period of no deaths seen in the Kaplan-Meier plot
(ﬁgures 2 and 3). Other limitations include unknown
dietary factors, postrehabilitation exercise and
medications.
However, our study shows that ﬁtness level in the early
weeks after a cardiac event or procedure was equally
important for cohorts with a wider range of initial
ﬁtness than previous studies, a wider age range, those
having signiﬁcant comorbidities and including women.
This analysis contributes to the body of research seeking
to identify risk factors for long-term mortality in patients
with coronary heart disease.
CONCLUSIONS
Pre-existing ﬁtness or improvement in ﬁtness within the
early months after a coronary event or procedure pre-
dicts long-term survival of patients. Fitness interventions
should take precedence over weight loss interventions.
Secondary prevention medications contribute signiﬁ-
cantly to improved long-term survival in all-cause and
cardiovascular mortality even when there is no informa-
tion on how long the medications were used, suggesting
that the effect is very strong. Patients having coronary
artery bypass surgery and PCI have a signiﬁcantly higher
long-term survival from cardiovascular mortality than do
patients with a MI or angina. Promotion of ﬁtness after
a coronary event or procedure may extend life
expectancy.
Contributors MT, FG, NP and MJB contributed to the study design. ST and
HB collected the data. ST was involved in editing and data preparation. MJB
and NP performed the analysis. MT, ST and MJB contributed to the first draft
of the manuscript. SW read and critically appraised several versions of the
manuscript. MJB had full access to the data in the study. MJB is the
guarantor. All the authors critically revised the manuscript for important
intellectual content, and approved the final version to be published.
Funding Financial support was provided by the Basingstoke and Alton
Cardiac Rehabilitation Charity Ltd, UK, and by an education grant to ST from
the UK Chartered Society of Physiotherapy. MJB was funded by EPSRC grant
number A.PXCX.0001.
Competing interests None declared.
Ethics approval Approval for this study was granted in 2001 from the North
and Mid Hampshire Local Research Ethics Committees reference 354/B.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The permanent URL for this dataset will be: http://
wrap.warwick.ac.uk/70379.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Gale CP, Manda SOM, Batin PD, et al. Predictors of in-hospital
mortality for patients admitted with ST-elevation myocardial
infarction: a real-world study using the Myocardial Infarction National
Audit Project (MINAP) database. Heart 2008;94:1407–12.
2. Greenhalgh J, Hockenhull J, Rao N, et al. Drug-eluting stents versus
bare metal stents for angina or acute coronary syndromes. Cochrane
Database Syst Rev 2010;(5):CD004587.
3. Nordmann AJ, Bucher H, Hengstler P, et al. Primary stenting versus
primary balloon angioplasty for treating acute myocardial infarction.
Cochrane Database Syst Rev 2005;(2):CD005313.
4. Vale N, Nordmann AJ, Schwartz GG, et al. Statins for acute
coronary syndrome. Cochrane Database Syst Rev 2011;(6):
CD006870.
5. Cervera R, Bakaeen FG, Cornwell LD, et al. Impact of functional
status on survival after coronary artery bypass grafting in a veteran
population. Ann Thorac Surg 2012;93:1950–4; discussion 1954–5.
6. Elfstrom KM, Hatefi D, Kilgo PD, et al. What happens after
discharge? An analysis of long-term survival in cardiac surgical
patients requiring prolonged intensive care. J Card Surg
2012;27:13–19.
7. Filardo G, Hamilton C, Grayburn PA, et al. Established preoperative
risk factors do not predict long-term survival in isolated coronary
artery bypass grafting patients. Ann Thorac Surg 2012;93:1943–8.
8. Grundtvig M. Patients with micro or other myocardial infarctions have
equal long-term survival. Scand Cardiovasc J 2012;46:76–80.
9. Shah A, Feldman DN. Outcome of the HORIZONS-AMI trial:
bivalirudin enhances long-term survival in patients with ST-elevation
myocardial infarction undergoing angioplasty. Vasc Health Risk
Manag 2012;8:115–23.
10. Shahian DM, O’brien SM, Sheng S, et al. Predictors of long-term
survival after coronary artery bypass grafting surgery: results from
the Society of Thoracic Surgeons Adult Cardiac Surgery Database
(the ASCERT study). Circulation 2012;125:1491–500.
11. Scarborough P, Allender S, Rayner M, et al. An index of unhealthy
lifestyle is associated with coronary heart disease mortality rates for
small areas in England after adjustment for deprivation. Health Place
2011;17:691–5.
12. Nichols M, Townsend N, Scarborough P, et al. Trends in
age-specific coronary heart disease mortality in the European Union
over three decades: 1980–2009. Eur Heart J 2013;34:3017–27.
13. Hardoon SL Whincup PH, Lennon LT, et al. How much of the recent
decline in the incidence of myocardial infarction in British men can
be explained by changes in cardiovascular risk factors? Evidence
from a prospective population-based study. Circulation
2008;117:598–604.
14. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary
heart disease mortality in England and Wales between 1981 and
2000. Circulation 2004;109:1101–7.
15. Bethell HJ, Larvan A, Turner SC. Coronary rehabilitation in the
community. J R Coll Gen Pract 1983;33:285–91.
16. Bethell HJ, Mullee MA. A controlled trial of community based
coronary rehabilitation. Br Heart J 1990;64:370–5.
17. Turner SC. Relationship of physical fitness, depression and mortality
in a cardiac rehabilitation cohort. Warwick Medical School, University
of Warwick, 2007.
18. Bethell H, Lewin R, Dalal H. Cardiac rehabilitation in the United
Kingdom. Heart 2009;95:271–5.
19. West RR, Jones DA, Henderson AH. Rehabilitation after myocardial
infarction trial (RAMIT): multi-centre randomised controlled trial of
comprehensive cardiac rehabilitation in patients following acute
myocardial infarction. Heart 2012;98:637–44.
20. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac
rehabilitation for coronary heart disease. Cochrane Database Syst
Rev 2011;(7):CD001800.
21. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk
factor for mortality in patients with coronary heart disease:
a meta-analysis. Psychosom Med 2004;66:802–13.
22. Melle JP, De Jonge P, Spijkerman TA, et al. Prognostic association
of depression following myocardial infarction with mortality and
cardiovascular events: a meta-analysis. Psychosom Med
2004;66:814–22.
23. Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital
Anxiety and Depression Scale. An updated literature review.
J Psychosom Res 2002;52:69–77.
24. D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the
use of the Charlson comorbidity index with administrative databases.
J Clin Epidemiol 1996;49:1429–33.
25. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and
nomographic assessment of functional aerobic impairment in
cardiovascular disease. Am Heart J 1973;85:546–62.
26. Bruce RA. Exercise testing and exercise training in coronary heart
disease. In: Hellerstein HK, eds. Principles in exercise testing.
New York, USA: Academic Press, 1973:45–61.
Barons MJ, et al. BMJ Open 2015;5:e007772. doi:10.1136/bmjopen-2015-007772 9
Open Access
27. Astrand PO, Rodahl K. Physiological basis of exercise. In: Text book
of work physiology. New York, USA: McGraw-Hill, 1986.
28. Kavanagh T, Mertens DJ, Hamm LF, et al. Peak oxygen intake and
cardiac mortality in women referred for cardiac rehabilitation. J Am
Coll Cardiol 2003;42:2139–43.
29. Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term
prognosis in 12,169 men referred for cardiac rehabilitation.
Circulation 2002;106:666–71.
30. Martin BJ, Arena R, Haykowsky M, et al. Cardiovascular fitness and
mortality after contemporary cardiac rehabilitation. Mayo Clin Proc
2013;88:455–63.
31. Collett D. Modelling survival data in medical research. In: Texts
in statistical science. Boca Raton: Chapman & Hall/CRC,
2003.
32. Akaike H. A new look at the statistical model identification. IEEE
Trans Automat Control. 1974;19:716–23.
33. R Development Core Team. R: a language and environment for
statistical computing. Vienna, Austria: R Foundation for Statistical
Computing, 2011.
34. Little RJA, Rubin DA. Statistical analysis with missing data.
In: Series in probability and statistics. New Jersey, USA:
Wiley-Interscience, 2002.
35. Hughes J, Kee F, Bennett K, et al. Modelling coronary heart disease
mortality in northern Ireland between 1987 and 2007. J Epidemiol
Community Health 2011;65(Suppl 2):A9–10.
36. Dallongevillle J, De Bacquer D, Heidrich J, et al. Gender differences
in the implementation of cardiovascular prevention measures after
an acute coronary event. Heart 2010;96:1744–9.
37. Heyward VH. Advance fitness assessment and exercise
prescription. 3rd en. Human Kinetics Europe Ltd, 1998.
38. Romero-Corral A, Montori VM, Somers VK, et al. Association of
bodyweight with total mortality and with cardiovascular events in
coronary artery disease: a systematic review of cohort studies.
Lancet 2006;368:666–78.
39. Barry VW, Baruth M, Beets MW, et al. Fitness vs. fatness on
all-cause mortality: a meta-analysis. Prog Cardiovasc Dis
2014;56:382–90.
40. Ekelund U, Ward HA, Norat T, et al Physical activity and all-cause
mortality across levels of overall and abdominal adiposity in European
men and women: the European Prospective Investigation into Cancer
and Nutrition Study (EPIC). Am J Clin Nutr 2015;101:613–21.
41. Dudas K, Lappas G, Rosengren A. Long-term prognosis after
hospital admission for acute myocardial infarction from 1987 to
2006. Int J Cardiol 2012;155:400–5.
10 Barons MJ, et al. BMJ Open 2015;5:e007772. doi:10.1136/bmjopen-2015-007772
Open Access
